Department of Protein Chemistry and Technology, CSIR- Central Food Technological Research Institute, Mysuru-, Karnataka, India.
Department of Biochemistry, CSIR- Central Food Technological Research Institute, Mysuru, Karnataka, India.
PLoS One. 2020 Apr 13;15(4):e0231543. doi: 10.1371/journal.pone.0231543. eCollection 2020.
Dipeptidyl peptidase-4 (DPP-4) is a proteolytic enzyme responsible for the rapid degradation of Glucagon-like peptide 1 (GLP-1) that is required for the secretion of insulin. DPP-4 also influences activation of node like receptor family, pyrin domain containing 3 (NLRP3) inflammasome under diabetic conditions. Although several polyphenols are reported for various bioactivities, they are consumed as part of the food matrix and not in isolation. Horsegram (Macrotyloma uniflorum) is a rich source of myricetin (Myr) (35 μg/g flour), reported for its anti-hyperglycemic effect. In this investigation, we aimed to study the effect of Myr, singly, and in the presence of co-nutrient horsegram protein (HP) on DPP-4 activity and its consequential impact on GLP-1, insulin, and NLRP3 inflammasome in high-fat diet and single low dose streptozotocin (STZ)-induced diabetic male Wistar rats. In diabetic control (DC), the activity of DPP-4 and its expression were higher compared to treated groups. The consequential decrease in the circulating GLP-1 levels in the DC group, but not treated groups, further indicated the effectiveness of our test molecules under diabetic conditions. Specifically, Myr decreased DPP-4 activity and its expression levels with enhanced circulating GLP-1 and insulin levels. Myr administration also resulted in a lessening of diabetes-induced NLRP3 inflammasome activation and enhanced antioxidant enzyme activities. HP also proved to be efficient in reducing elevated blood glucose levels and enhancing antioxidant enzyme activities. However, Myr, in the presence of HP as a co-nutrient, had diminished capacity to inhibit DPP-4 and, consequently, reduced potential in ameliorating diabetic conditions. Myr proved to be a potent inhibitor of DPP-4 in vitro and in vivo, resulting in enhanced circulating GLP-1 and insulin levels, thereby improving diabetic conditions. Though Myr and HP, individually ameliorate diabetic conditions, their dietary combination had reduced efficiency.
二肽基肽酶-4(DPP-4)是一种蛋白水解酶,负责快速降解胰高血糖素样肽 1(GLP-1),而 GLP-1 是胰岛素分泌所必需的。在糖尿病条件下,DPP-4 还影响模式识别受体家族、含吡喃结构域蛋白 3(NLRP3)炎性小体的激活。尽管有几种多酚因其各种生物活性而被报道,但它们是作为食物基质的一部分被消耗的,而不是单独消耗的。马豆(Macrotyloma uniflorum)是杨梅素(Myr)(面粉中 35μg/g)的丰富来源,具有抗高血糖作用。在这项研究中,我们旨在研究 Myr 单独使用以及与共同营养物马豆蛋白(HP)一起使用对 DPP-4 活性及其对高脂肪饮食和单低剂量链脲佐菌素(STZ)诱导的糖尿病雄性 Wistar 大鼠 GLP-1、胰岛素和 NLRP3 炎性小体的影响。在糖尿病对照组(DC)中,与处理组相比,DPP-4 的活性及其表达更高。DC 组循环 GLP-1 水平下降,但处理组没有,这进一步表明我们的测试分子在糖尿病条件下是有效的。具体而言,Myr 降低了 DPP-4 活性及其表达水平,同时增加了循环 GLP-1 和胰岛素水平。Myr 给药还导致糖尿病诱导的 NLRP3 炎性小体激活减少和抗氧化酶活性增强。HP 也被证明能有效降低升高的血糖水平并增强抗氧化酶活性。然而,Myr 与 HP 作为共同营养物一起使用时,抑制 DPP-4 的能力减弱,因此改善糖尿病状况的潜力降低。Myr 在体外和体内均被证明是 DPP-4 的有效抑制剂,导致循环 GLP-1 和胰岛素水平升高,从而改善糖尿病状况。虽然 Myr 和 HP 单独改善糖尿病状况,但它们的饮食组合效率降低。